“The brand has carved a unique space in the RTD category,” Sazerac CEO Jake Wenz said.

Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management of HAE ZUG, Switzerland, March 20, 2026 (GLOBE NEWSWIRE) ...

Nvidia unveiled its open-source Agent Toolkit at GTC 2026, adding OpenShell, AI-Q, and major partners including Adobe, SAP, ...

Free spins no deposit bonus offers have become the most competitive battleground in American online gaming for 2026. As more ...

VinFast Auto Ltd. ("VinFast" or the "Company") (Nasdaq: VFS), a pure-play electric vehicle ("EV") manufacturer with the mission of making EVs accessible to everyone, today announced its preliminary ...